Table 4.

Determinants for myocardial mechanical function

	β	t	p-value
LV GLS endocardium (R2 = 0.327)
Age	−0.170	−1.48	0.142
Female gender	−0.112	−1.22	0.225
Body mass index	0.046	0.49	0.626
Diabetes mellitus	0.062	0.66	0.511
Peripheral SBP	0.024	0.26	0.795
LV ejection fraction	−0.419	−4.44	<0.001
LV mass index	−0.001	−0.01	0.995
Use of RAAS blocker	0.158	1.76	0.082
PWV	0.223	2.19	0.031
LV GCS endocardium (R2 = 0.164)
Age	0.190	1.21	0.231
Female gender	−0.130	−1.06	0.294
Body mass index	0.076	0.63	0.534
Diabetes mellitus	0.108	0.87	0.385
Peripheral SBP	0.004	0.04	0.970
LV ejection fraction	−0.293	−2.35	0.022
LV mass index	−0.015	−0.13	0.896
Use of RAAS blocker	−0.091	−0.76	0.448
Log Aldosterone	0.201	1.61	0.112
LA GLS (R2 = 0.361)
Age	−0.118	−1.05	0.297
Female gender	−0.096	−1.06	0.292
Body mass index	−0.179	−1.94	0.055
Diabetes mellitus	−0.158	−1.70	0.092
Peripheral SBP	−0.044	−0.50	0.622
LV ejection fraction	0.218	2.35	0.021
LV mass index	−0.065	−0.74	0.461
Use of RAAS blocker	−0.318	−3.59	0.001
PWV	−0.311	−3.12	0.002

SBP systolic blood pressure, LV left ventricle, RAAS renin angiotensin aldosterone system, PWV pulse wave velocity